Given that the pharmacologic antagonist of CXCR3 affects the proliferation and the migratory behaviour of both human and murine CRC cell lines in vitro, we tested whether a systemic treatment with AMG487 could affect local growth of pre-established metastases. The gene discussed is CXCR3; the disease is colorectal carcinoma.